CK Life Sciences Files Board of Directors List with HKEX

Reuters
11/03
CK Life Sciences Files Board of Directors List with HKEX

CK Life Sciences International (Holdings) Inc. has filed an updated list of directors with the Hong Kong Stock Exchange. The Board is led by Executive Directors LI Tzar Kuoi, Victor (Chairman), KAM Hing Lam (President), IP Tak Chuen, Edmond (Senior Vice President and Chief Investment Officer), YU Ying Choi, Alan Abel (Deputy Chairman), Lance Richard LEE YUEN (Vice President and Chief Executive Officer), and TOH Kean Meng, Melvin (Vice President and Chief Scientific Officer). Non-executive Directors include Peter Peace TULLOCH and Independent Non-executive Directors KWOK Eva Lee, KWAN Kai Cheong, Paul Joseph TIGHE, and Donald Jeffrey ROBERTS. Board committee memberships are as follows: KWAN Kai Cheong chairs the Audit Committee; KWOK Eva Lee chairs the Remuneration Committee and is a member of the Nomination Committee; Paul Joseph TIGHE chairs the Nomination and Sustainability Committees and is a member of the Audit Committee; Donald Jeffrey ROBERTS is a member of the Audit, Remuneration, and Nomination Committees. LI Tzar Kuoi, Victor is a member of the Remuneration and Nomination Committees and chairs the Executive Committee. Other Executive Directors serve as members of the Executive Committee, with IP Tak Chuen, Edmond also serving on the Sustainability Committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CK Life Sciences International (Holdings) Inc. published the original content used to generate this news brief on November 03, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10